Suchergebnisse - "Tsunenari, Takazumi"

PubPharm (24)

1

Impact of Preoperative Tumor Size on Prognosis of Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinomas

enthalten in: Annals of surgical oncology | 2023

von Miyata, Y. | Yonamine, N. | Fujinuma, I. | +11

CommentIn: Ann Surg Oncol. 2023 Dec;30(13):8644-8645. - PMID 37689609

2

Prognosis of Pancreatic Cancer Based on Resectability : A Single Center Experience

enthalten in: Cancers | 2023

von Einama, T. | Takihata, Y. | Aosasa, S. | +9

3

Preoperative Rapid Weight Loss as a Prognostic Predictor After Surgical Resection for Pancreatic Cancer

enthalten in: Pancreas | 2022

von Nishikawa, M. | Yamamoto, J. | Einama, T. | +6

4

Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer : a retrospective study

enthalten in: BMC cancer | 2022

von Kobayashi, K. | Einama, T. | Takihata, Y. | +8

5

Therapeutic efficacy of dose-reduced adjuvant chemotherapy with S-1 in patients with pancreatic cancer: a retrospective study

enthalten in: BMC cancer | 2022

von Kobayashi, K. | Einama, T. | Takihata, Y. | +8

6

Clinical Impact of Dual Time Point 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Fusion Imaging in Pancreatic Cancer

enthalten in: Cancers | 2022

von Einama, T. | Yamagishi, Y. | Takihata, Y. | +12

7

Impact of Lymph Node Metastases Around the Superior Mesenteric Artery on Postoperative Outcomes of Pancreatic Head Cancer

enthalten in: World journal of surgery | 2021

von Miyata, Y. | Yonamine, N. | Fujinuma, I. | +8

8

COVID-19 with essential thrombocythemia treated with apixaban for antithrombotic prophylaxis

enthalten in: BMJ case reports | 2021

von Takasaki, K. | Tsunenari, T. | Mori, K. | +1

9

Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients

enthalten in: Biomarker research | 2021

von Einama, T. | Yamagishi, Y. | Takihata, Y. | +19

10

Co-expression of mesothelin and CA125/MUC16 is a prognostic factor for breast cancer, especially in luminal-type breast cancer patients

enthalten in: Biomarker Research | 2021

von Einama, T. | Yamagishi, Y. | Takihata, Y. | +19